Substituted pyrido-or pyrimido-containing 6,6-  or 6,7-bicyclic derivatives
This invention relates to compounds of formula (I), wherein A, B, D, E, K, G, Z, R3 and R5 are defined as in the specification, and to the pharmaceutically acceptable salts of such compounds. Compounds (I) are corticotropin releasing factor (hormone) CRF (CRH) antagonists. 
Pfizer Inc
A A A C A A A A A A A
A61P A61P A61P C07D A61P A61P A61P A61P A61P A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Yuhpyng L.
Chen